Evaluation of an At-Home-Use Prostate Massage Device for Men with Lower Urinary Tract Symptoms
Jillian L. Capodice, Brian A. Stone , Aaron E. Katz*
Identifiers and Pagination:Year: 2009
First Page: 20
Last Page: 23
Publisher ID: TOUNJ-2-20
Article History:Received Date: 11/5/2009
Revision Received Date: 12/8/2009
Acceptance Date: 13/8/2009
Electronic publication date: 1/10/2009
Collection year: 2009
open-access license: This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.5/), which permits unrestrictive use, distribution, and reproduction in any medium, provided the original work is properly cited.
Treatment of lower urinary tract symptoms (LUTS) in men due to benign prostatic hyperplasia (BPH) or chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) are difficult for both the patient and the clinician. In office prostatic massage has been documented to provide symptom relief but use of at-home massage has not been determined. We performed a retrospective analysis of data from men utilizing an at-home-use prostate device to examine disease, treatment characteristics, and symptom relief in order to ascertain whether evidence exists to perform a clinical trial.
Data on 154 consecutive men was reviewed and subjects evaluated in two Groups, BPH w/ LUTS (Group 1) and CP/CPPS w/ LUTS (Group 2). All subjects completed the National Institutes of Health, Chronic Prostatitis Symptom Index (CPSI) at baseline and follow-up. Demographics, scores on the CPSI, duration of device use, self-reported symptom assessment, and comments were analyzed.
Of 154 men, 115 were analyzed. Of the 115, 90 (78.3%) were in Group 1 (BPH w/LUTS) and 25 (21.7%) were in Group 2 (CP/CPPS w/LUTS). The average age was 64.48 years 10.86 (average SD) vs 46.68 12.5 (Group 1 - 2, respectively). In Group 1 total CPSI score from baseline to follow-up were (11.61 7.07 (mean SD) - 6.63 5.20, p = 0.0001). In Group 2 total scores from baseline to follow-up were (16.67 7.0 vs 11.48 5.84 (5.20, p = 0.0127). Other self-reported comments included 16/115 (13.9%) of subjects unsure about proper use/application and 10/115 (8.6%) reporting rectal soreness.
The preliminary findings suggest that a clinical trial of a novel at-home-use prostatic massage device is warranted.